Tiny RNA fragments can predict two-year survival better than traditional health metrics. Researchers from Duke Health and the ...
A recent study shows that accessible blood tests can accurately identify Alzheimer’s disease. When combined with standard cognitive assessments, these tools offer a reliable diagnostic approach for ...
A new whole genome platform integrates on-flow cell library prep and advanced informatics to deliver comprehensive variant ...
Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, ...
On a Tuesday in October, I sat on the edge of my bed with a notebook and a felt-tip pen and wrote: “I’m grateful for the ...
Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a suite of powerful advancements that will significantly accelerate the next era of ...
Heterotopic ossification (HO) is a common post-surgery condition where bone abnormally forms within soft tissues. A new study out of Mass General Brigham assesses the viability of a simple blood test ...
Heterotopic ossification (HO) is a common post-surgery condition where bone abnormally forms within soft tissues. A new study out of Mass General Brigham assesses the viability of a simple blood test ...
With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...
A new report shows that agricultural corporations and big tech is pricing innovation out of reach of smallholder farmers who need it most.
A genetic test meant to introduce you to a lost cousin could also introduce info on your entire lineage to a stranger seeking profit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results